trending Market Intelligence /marketintelligence/en/news-insights/trending/a9l0tJKU2b21vmDZNa1g7A2 content esgSubNav
In This List

Invitrocue plans common stock, warrants placement

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Invitrocue plans common stock, warrants placement

Invitrocue Ltd. plans to offer up to 18,647,936 ordinary shares and 4,661,981 warrants via a placement.

The securities will be priced 8 Australian cents apiece.

The warrants have an exercise price of 8 cents and a validity of five years.

Invitrocue will use proceeds for working capital.

As of Dec. 6, US$1 was equivalent to A$1.32.